MedTech Acquisition Corp (MTAC)
$11.34
$1.78
(18.67%)
As on 10-Aug-2023 16:00EDT
Market cap
$84 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
226.8
P/B Ratio
1.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-1 Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-124.1
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
7,394,790
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
MedTech Acquisition Corp (MTAC)
| 13.1 | 7.9 | 10.0 | 14.6 | -- | -- | -- |
|
BSE Sensex*
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2022
|
|---|---|
|
MedTech Acquisition Corp (MTAC)
| 1.5 |
|
S&P Small-Cap 600
| -17.4 |
|
BSE Sensex
| 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
MedTech Acquisition Corp (MTAC)
|
11.3 | 83.9 | 0.0 | -1.1 | -- | -- | 226.8 | 1.3 |
| 10.2 | 436.4 | 1.3 | 9.6 | -126.3 | 2.9 | 42.7 | 1.3 | |
| 11.7 | 115.7 | 0.0 | 5.6 | -- | 4.1 | -- | 0.0 | |
| 26.5 | 113.6 | 0.0 | 4.3 | -- | 6.9 | 28.5 | 0.0 |
Shareholding Pattern
View DetailsAbout MedTech Acquisition Corp (MTAC)
MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the... healthcare sector in the United States. The company was incorporated in 2020 and is based in Greenwich, Connecticut. MedTech Acquisition Corporation operates as a subsidiary of Medtech Acquisition Sponsor LLC. Read more
-
CEO & Director
Mr. Christopher C. Dewey
-
CEO & Director
Mr. Christopher C. Dewey
-
Headquarters
Greenwich, CT
-
Website
--
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for MedTech Acquisition Corp (MTAC)
What is the current share price of MedTech Acquisition Corp (MTAC) Today?
The share price of MedTech Acquisition Corp (MTAC) is $11.34 (NASDAQ) as of 10-Aug-2023 16:00 EDT. MedTech Acquisition Corp (MTAC) has given a return of 14.6% in the last 1 years.
What is the current PB & PE ratio of MedTech Acquisition Corp (MTAC)?
The P/E ratio of MedTech Acquisition Corp (MTAC) is 226.80 times as on 10-Aug-2023.
The P/B ratio of MedTech Acquisition Corp (MTAC) is 1.31 times as on 10-Aug-2023, a 61 discount to its peers’ median range of 3.39 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2022 |
-- |
-- |
2021 |
-- |
-- |
2020 |
-- |
-- |
2022 |
-- |
-- |
2021 |
-- |
-- |
What is the 52 Week High and Low of MedTech Acquisition Corp (MTAC)?
The 52-week high and low of MedTech Acquisition Corp (MTAC) are Rs -- and Rs -- as of 29-Aug-2026.
What is the market cap of MedTech Acquisition Corp (MTAC)?
MedTech Acquisition Corp (MTAC) has a market capitalisation of $ 84 Mln as on 10-Aug-2023. As per SEBI classification, it is a Small Cap company.
Should I invest in MedTech Acquisition Corp (MTAC)?
Before investing in MedTech Acquisition Corp (MTAC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.